Doctor profile · Federal record

Dr. George Howard, M.D.

Hematology & Oncology Physician (CMS: Medical Oncology) · Sterling Heights, MI

  • NPI 1144372004
  • Accepts Medicare
  • 24 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
44344 Dequindre RD, Suite 260
Sterling Heights, MI 483141038
(586) 323-1500
fax (586) 323-1515

Credentials & registration

NPPES · NUCC
NPI registered
January 2007 — 19 yrs on file
Profile last updated
October 22, 2020
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Michigan #4301080073

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1144372004. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
111,283
Distinct HCPCS
10
Medicare allowed
$1,357,975
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 58,650 68 $0
J9271 Injection, pembrolizumab, 1 mg 14,800 29 $50
J9263 Injection, oxaliplatin, 0.5 mg 11,600 11 $0
J1453 Injection, fosaprepitant, 1 mg 5,250 18 $0
J0897 Injection, denosumab, 1 mg 5,220 22 $23
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 2,190 15 $28
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 1,920 16 $8
J1626 Injection, granisetron hydrochloride, 100 mcg 1,690 60 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,676 70 $0
36415 Insertion of needle into vein for collection of blood sample 993 509 $8

In context: peer comparison

Among 3 peers in Sterling Heights Hematology & Oncology Physician, average services per provider: 1,743. This provider delivers 64× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$479
Transactions
22
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
BeiGene USA, INC. 3 $64.11
Abbvie INC. 3 $55.84
Genzyme Corporation 2 $46.94
Adaptive Biotechnologies Corporation 2 $44.40
Takeda Pharmaceuticals U.S.A., INC. 1 $34.81
Servier Pharmaceuticals LLC 2 $33.39
Merck Sharp & Dohme LLC 1 $32.86
AstraZeneca Pharmaceuticals Lp 1 $27.97
Boston Scientific Corporation 1 $26.90
Jazz Pharmaceuticals INC. 1 $25.22
Genentech USA, INC. 1 $22.46
Janssen Biotech, INC. 1 $21.89
Celgene Corporation 1 $21.17
Daiichi Sankyo INC. 1 $19.47
Array Biopharma INC 1 $1.85

By nature of payment

Food and Beverage
$479

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,192
Patients
467
Total drug cost
$1,115,846
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 200 49 $202,116
Prochlorperazine Maleate Generic 166 119 $2,678
Valacyclovir (Valacyclovir Hcl) Brand 96 27 $4,093
Omeprazole Generic 81 29 $1,021
Hydroxyurea Generic 76 18 $2,421
Ondansetron Hcl Generic 72 57 $706
Letrozole Generic 71 21 $3,626
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 67 23 $2,578
Xarelto (Rivaroxaban) Brand 65 19 $78,050
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 54 16 $301

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. George Howard's medical specialty?
Dr. George Howard practices Hematology & Oncology Physician in Sterling Heights, MI.
Where does Dr. George Howard practice?
Dr. George Howard practices at 44344 Dequindre RD, Sterling Heights, MI 483141038. Office phone: 5863231500.
What is Dr. George Howard's NPI?
Dr. George Howard's National Provider Identifier (NPI) is 1144372004, issued by NPPES.
Does Dr. George Howard accept Medicare assignment?
Yes. Dr. George Howard accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. George Howard commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.